This company listing is no longer active
Salud financiera de hoja de balance de Global Blood Therapeutics
Salud financiera controles de criterios 2/6
Información clave
491.7%
Ratio deuda-patrimonio
US$581.95m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$517.16m |
| Patrimonio | US$118.36m |
| Total pasivo | US$752.08m |
| Activos totales | US$870.44m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: G5B's short term assets ($640.0M) exceed its short term liabilities ($93.1M).
Pasivo a largo plazo: G5B's short term assets ($640.0M) do not cover its long term liabilities ($659.0M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: G5B's net debt to equity ratio (54.7%) is considered high.
Reducción de la deuda: Insufficient data to determine if G5B's debt to equity ratio has reduced over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: G5B has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if G5B has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.